Healthcare >> CEO Interviews >> December 13, 1999

Douglas C. Stafford – Ophidian Pharmaceuticals Inc (ophd)

DOUGLAS C. STAFFORD holds the position of President and Chief Executive Officer at Ophidian Pharmaceuticals, Inc., a position he has held since initiating its operations in August of 1990. He has been responsible for various aspects of business administration with primary emphasis on strategic planning, organizational development and corporate development. Dr. Stafford was previously employed at the Baxter Healthcare Corporation where he held senior management positions in research and development and manufacturing operations at several of its operating divisions (including the Travenol-Genentech, Dade and Pandex divisions). Prior to Baxter, Dr. Stafford was employed at Sensor Diagnostics, Inc. and held a faculty position in Immunology at the University of Detroit. He received BS and MS degrees in Biology from the University of Detroit, a Ph.D. in Immunology from the Tufts University School of Medicine and a MS in Management from Lesley College. Profile
TWST: Could you begin by giving us from your own perspective and

experience with the company an historical summary on Ophidian

Pharmaceuticals? Based on that background, tell us what you see as